Evaluating the accuracy and large inaccuracy of two continuous glucose monitoring systems

Diabetes Technology and Therapeutics

Volumn 15, Issue 2, 2013, Pages 143-149

  Leelarathna, Lalantha ^a   Nodale, Marianna ^a   Allen, Janet M ^a   Elleri, Daniela ^a   Kumareswaran, Kavita ^a   Haidar, Ahmad ^a   Caldwell, Karen ^a   Wilinska, Malgorzata E ^a   Acerini, Carlo L ^a   Evans, Mark L ^a   Murphy, Helen R ^a   Dunger, David B ^a   Hovorka, Roman ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CONTINUOUS GLUCOSE MONITORING SYSTEM; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; MEASUREMENT ERROR; MONITOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SENSOR;

ADOLESCENT; ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; DRUG DELIVERY SYSTEMS; ENGLAND; EQUIPMENT DESIGN; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SELF CARE;

EID: 84873147427     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0245     Document Type: Article

References (29)

1. De Beaufort CE, Swift PG, Skinner CT, Aanstoot HJ, Aman J, Cameron F, Martul P, Chiarelli F, Daneman D, Danne T, Dorchy H, Hoey H, Kaprio EA, Kaufman F, Kocova M, Mortensen HB, Njolstad PR, Phillip M, Robertson KJ, Schoenle EJ, Urakami T, Vanelli M, Hvidoere Study Group on Childhood D: Continuing stability of center differences in pediatric diabetes care: Do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood Diabetes. Diabetes Care 2007;30:2245-2250
2. Cryer PE: Elimination of hypoglycemia from the lives of people affected by diabetes. Diabetes 2011;60:24-27
3. Hovorka R: Closed-Loop insulin delivery: From bench to clinical practice. Nat Rev Endocrinol 2011;7:385-395
4. Hovorka R, Allen J, Elleri D, Chassin L, Harris J, Xing D, Kollman C, Hovorka T, Larsen A, Nodale M, De Palma A, Wilinska M, Acerini C, Dunger D:Manual closed-Loop insulin delivery in children and adolescents with type 1 diabetes: A phase 2 randomised crossover trial. Lancet 2010;375:743-751
5. Hovorka R, Kumareswaran K, Harris J, Allen JM, Elleri D, Xing D, Kollman C, Nodale M, Murphy HR, Dunger DB, Amiel SA, Heller SR, Wilinska ME, Evans ML: Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: Crossover randomised controlled studies. BMJ 2011;342:d1855
6. Murphy HR, Elleri D, Allen JM, Harris J, Simmons D, Rayman G, Temple R, Dunger DB, Haidar A, Nodale M, Wilinska ME, Hovorka R: Closed-Loop insulin delivery during pregnancy complicated by type 1 diabetes. Diabetes Care 2011;34:406-411
7. Murphy HR, Kumareswaran K, Elleri D, Allen JM, Caldwell K, Biagioni M, Simmons D, Dunger DB, Nodale M, Wilinska ME, Amiel SA, Hovorka R: Safety and efficacy of 24-h closed-Loop insulin delivery in well-controlled pregnant women with type 1 diabetes: A randomized crossover case series. Diabetes Care 2011;34:2527-2529
8. Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV: Fully automated closed-Loop insulin delivery versus sermautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008;31:934-939
9. Kovatchev B, Cobelli C, Renard E, Anderson S, Breton M, Patek S, Clarke W, Bruttomesso D, Maran A, Costa S, Avogaro A, Dalla Man C, Facchinetti A, Magni L, De Nicolao G, Place J, Farret A: Multinational study of subcutaneous model-predictive closed-Loop control in type 1 diabetes mellitus: Summary of the results. J Diabetes Sci Technol 2010;4:1374-1381
10. Atlas E, Nimri R, Miller S, Grunberg EA, Phillip M: MDLogic Artificial Pancreas System: A pilot study in adults with type 1 diabetes. Diabetes Care 2010;33:1072-1076
11. Castle JR, Engle JM, El Youssef J, Massoud RG, Yuen KCJ, Kagan R, Ward WK: Novel use of glucagon in a closed-Loop system for prevention of hypoglycemia in type 1 diabetes. Diabetes Care 2010;33:1282-1287
12. Breton M, Farret A, Bruttomesso D, Anderson S, Magni L, Patek S, Dalla Man C, Place J, Demartini S, Del Favero S, Toffanin C, Hughes-Karvetski C, Dassau E, Zisser H, Doyle FJ, 3rd, De Nicolao G, Avogaro A, Cobelli C, Renard E, Kovatchev B; International Artificial Pancreas Study G: Fully integrated artificial pancreas in type 1 diabetes: Modular closed-Loop glucose control maintains near normoglycemia. Diabetes 2012;61:2230-2237
13. Garg SK, Voelmle M, Gottlieb PA: Time lag characterization of two continuous glucose monitoring systems. Diabetes Res Clin Pract 2010;87:348-353
14. Elleri D, Allen J, Kumareswaran K, Leelarathna L, Nodale M, Caldwell K, Murphy H, Wilinska M, Acerini C, Dunger D, Hovorka R: Day-And-night closed-Loop (CL) glucose control in adolescents with type 1 diabetes (T1D) [abstract]. Diabetes 2011;60(SUPPL1):A41-A42
15. DeVries J, Avogaro A, Benesch C, Bruttomesso D, Caldwell K, Cobelli C, Doll W, Del Favero S, Heinemann L, Hovorka R, Leelarathna L, Luijf Y, Mader J, Magni L, Nodale M, Place J, Renard E, Toffanin C; AP@home Consortium: Comparison of two closed loop algorithms with open loop control in type 1 diabetes [abstract]. Diabetes 2012;61(SUPPL1):A60
16. Elleri D, Allen J, Biagioni M, Kumareswaran K, Leelarathna L, Caldwell K, Nodale M, Wilinska M, Calhoun P, Kollman C, Acerini C, Dunger D, Hovorka R: Closed-Loop (CL) insulin delivery with reduced meal insulin bolus to minimize risk of postmeal hypoglycemia in adolescents with type 1 diabetes (T1D) [abstract]. Diabetes 2012;61(SUPPL1):A227
17. Geoffrey M, Brazg R, Richard W: FreeStyle Navigator continuous glucose monitoring system with TRUstart algorithm, a 1-hour warm-up time. J Diabetes Sci Technol 2011; 5:99-106
18. Clarke W, Cox D, Gonder-Frederick L, Carter W, Pohl S: Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 1987;10:622-628
19. Clarke W, Kovatchev B: Statistical tools to analyze continuous glucose monitor data. Diabetes Technol Ther 2009; 11(SUPPL1):S45-S54
20. International Organization for Standardization: In Vitro Diagnostic Test Systems: Requirements for Blood-Glucose Monitoring Systems for Self-Testing in Managing Diabetes Mellitus. ISO publication 15197. Geneva: International Organization for Standardization, 2003
21. Parkes JL, Slatin SL, Pardo S, Ginsberg BH: A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care 2000;23:1143-1148
22. Weinstein RL, Schwartz SL, Brazg RL, Bugler JR, Peyser TA, McGarraugh GV: Accuracy of the 5-Day FreeStyle Navigator continuous glucose monitoring system: Comparison with frequent laboratory reference measurements. Diabetes Care 2007;30:1125-1130
23. Kovatchev B, Anderson S, Heinemann L, Clarke W: Comparison of the numerical and clinical accuracy of four continuous glucose monitors. Diabetes Care 2008;31:1160-1164
24. Bailey T, Zisser H, Chang A: New features and performance of a next-Generation SEVEN-Day continuous glucose monitoring system with short lag time. Diabetes Technol Ther 2009;11:749-755
25. Garg SK, Smith J, Beatson C, Lopez-Baca B, Voelmle M, Gottlieb PA: Comparison of accuracy and safety of the SEVEN and the Navigator continuous glucose monitoring systems. Diabetes Technol Ther 2009;11:65-72
26. Wilinska ME, Budiman ES, Taub MB, Elleri D, Allen JM, Acerini CL, Dunger DB, Hovorka R: Overnight closed-Loop insulin delivery with model predictive control: Assessment of hypoglycemia and hyperglycemia risk using simulation studies. J Diabetes Sci Technol 2009;3:1109-1120
27. Kovatchev BP, Gonder-Frederick LA, Cox DJ, Clarke WL: Evaluating the accuracy of continuous glucose-monitoring sensors: Continuous glucose-Error grid analysis illustrated by TheraSense Freestyle Navigator data. Diabetes Care 2004;27: 1922-1928
28. Price DA, Nakamura K, Kamath A, Boock R: Dexcom G4, a next generation continuous glucose monitoring (CGM) system, demonstrates a strong correlation to self-monitored blood glucose (SMBG) [abstract]. Diabetes 2012;61(SUPPL1):A588
29. Garcia A, Mahalingam A, Kamath A: Consistent performance of Dexcom G4 when calibrated at different rates-of-change (ROC) [abstract]. Diabetes 2012;61(SUPPL1): A586